EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sensing‐Integrated Patient‐Derived Tumorspheres Predict Chemotherapeutic Efficacy via Local Extracellular pH Dynamics

Stefania Forciniti iD, Valentina Onesto iD, Anna Chiara Siciliano iD, Helena Iuele iD, Stefano D'Ugo, Norma Depalma, Cinzia Fasano, Alessandro D'Amuri, Giuseppe Gigli, Marcello G Spampinato, Loretta L Del Mercato iD

Small · 2026

DOI: 10.1002/smll.75149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2026. Verfasst von Stefania Forciniti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nanotechnology, National Research Council (CNR-NANOTEC), c/o Campus Ecotekne, Lecce, Italy. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation program ERC Proof of Concept "HySENSE", ERC Starting Grant "INTERCELLMED", Associazione Italiana per la Ricerca contro il Cancro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest malignancies, due to late diagnosis, poor therapeutic response, and high inter‐ and intra‐patient heterogeneity. Metabolic alterations, particularly extracellular acidification, critically impair drug response yet remain underexplored in clinical stratification. We present a sensing‐integrated 3D platform that enables non‐invasive time‐resolved mapping of pH dynamics in patient‐derived tumorspheres. Primary PDAC cells from five patients were embedded in an alginate‐based matrix incorporating ratiometric optical pH sensors, allowing real‐time monitoring of local extracellular acidification associated with individual cells during treatment. In contrast to existing bulk or invasive methods, our platform captures extracellular acidification dynamics with high spatial and temporal resolution in a 3D model with potential clinical relevance. Distinct extracellular acidification profiles emerged in response to FOLFIRINOX, gemcitabine, and paclitaxel. These metabolic signatures correlated with treatment efficacy and highlighted patient‐specific drug sensitivities. This platform offers a rapid, scalable tool for personalized drug screening and highlights a potential role of pH metabolic heterogeneity in PDAC chemoresistance. It may complement existing clinical workflows by providing early predictive insights into patient‐specific therapeutic outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsAntineoplastic AgentsHumansHydrogen-Ion ConcentrationCell Line, TumorPaclitaxelTreatment Outcome

Stichwörter der Autor:innen

metabolic pH heterogeneitypancreatic ductal adenocarcinomapatient‐derived tumorspherespersonalized drug screeningtumor microenvironment

Substanzen

Antineoplastic AgentsPaclitaxel

Autor:innen und Institutionen

  • Institute of Nanotechnology, National Research Council (CNR-NANOTEC), c/o Campus Ecotekne, Lecce, Italy.
  • Tecnomed Puglia - Technopole for Precision Medicine (Biotech Lecce Hub), c/o Campus Ecotekne, Lecce, Italy.
  • Department of Surgery "Vito Fazzi" Hospital, Lecce, Italy.
  • UOC of Pathological Anatomy "Vito Fazzi" Hospital, Lecce, Italy.
  • Department of Experimental Medicine, University of Salento, c/o Campus Ecotekne, Lecce, Italy.

ORCID-Profile: Stefania Forciniti, Valentina Onesto, Anna Chiara Siciliano, Helena Iuele, Loretta L Del Mercato

Förderung

  • European Union's Horizon 2020 research and innovation program ERC Proof of Concept "HySENSE"
  • ERC Starting Grant "INTERCELLMED"
  • Associazione Italiana per la Ricerca contro il Cancro
  • "Tecnopolo per la medicina di precisione" (TecnoMed Puglia) - Regione Puglia
  • talian Ministry of University and Research, under the complementary actions to the NRRP 'Fit4MedRob - Fit for Medical Robotics' Grant

Zitieren

APA

Forciniti, S., Onesto, V., Siciliano, A. C., Iuele, H., D'Ugo, S., Depalma, N., Fasano, C., D'Amuri, A., Gigli, G., Spampinato, M. G., & Del Mercato, L. L. (2026). Sensing‐Integrated Patient‐Derived Tumorspheres Predict Chemotherapeutic Efficacy via Local Extracellular pH Dynamics. Small. https://doi.org/10.1002/smll.75149

Vancouver

Forciniti S, Onesto V, Siciliano AC, Iuele H, D'Ugo S, Depalma N, et al. Sensing‐Integrated Patient‐Derived Tumorspheres Predict Chemotherapeutic Efficacy via Local Extracellular pH Dynamics. Small. 2026. doi:10.1002/smll.75149

BibTeX
@article{Forciniti2026,
  author = {Forciniti, Stefania and Onesto, Valentina and Siciliano, Anna Chiara and Iuele, Helena and D'Ugo, Stefano and Depalma, Norma and Fasano, Cinzia and D'Amuri, Alessandro and Gigli, Giuseppe and Spampinato, Marcello G and Del Mercato, Loretta L},
  title = {Sensing‐Integrated Patient‐Derived Tumorspheres Predict Chemotherapeutic Efficacy via Local Extracellular pH Dynamics},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.75149}
}
Kostenlos starten →